Company Search:
Advanced Search
Sponsored Links
Orexo Ab Company Snapshot
Orexo Ab operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Orexo Ab with three other pharmaceutical manufacturers in Europe: Antibiotice SA of ROMANIA (2019 sales of 389.71 million Romanian Leu [US$93.30 million] ), Eco Animal Health Group Plc of UNITED KINGDOM (£74.58 million [US$94.88 million] of which 38% was China & Japan), and Allergy Therapeutics PLC which is also based in UNITED KINGDOM (£73.72 million [US$93.79 million] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2019, sales at Orexo Ab were SEK 844.80 million (US$93.65 million). This is an increase of 7.9% versus 2018, when the company's sales were SEK 783.10 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Orexo Ab
  Stock Performance Chart for Orexo Ab
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 53.00
(Figures in Swedish Kronor)
1 Week 2.7%   13 Weeks 7.2%  
4 Weeks -29.3%   52 Weeks -3.8%  
Orexo Ab Key Data:
  Ticker: ORX Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 844,800,000
(Year Ending Jan 2020).
Employees: 127
  Currency: Swedish Kronor Market Cap: 1,881,002,330
  Fiscal Yr Ends: December Shares Outstanding: 35,490,610
  Share Type: Aktie Closely Held Shares: 3,659,071
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.